Refreshing results…
Rituximab (Rituxan) Therapy for Severe Thyroid-Associated Ophthalmopathy Diminishes IGF-1R+ T Cells
Download from academic.oup.comTeprotumumab, an IGF-1R Blocking Monoclonal Antibody Inhibits TSH and IGF-1 Action in Fibrocytes
Download from academic.oup.comHuman Fibrocytes Express Multiple Antigens Associated With Autoimmune Endocrine Diseases
Download from academic.oup.comRegulation of IL-1 Receptor Antagonist by TSH in Fibrocytes and Orbital Fibroblasts
Download from academic.oup.comCurrent Concepts in the Molecular Pathogenesis of Thyroid-Associated Ophthalmopathy
Download from iovs.arvojournals.orgIs IGF-I Receptor a Target for Autoantibody Generation in Graves' Disease?
Download from academic.oup.comRole of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves’ orbitopathy
Download from www.ncbi.nlm.nih.govHuman fibrocytes coexpress thyroglobulin and thyrotropin receptor
Download from doi.orgThyroid Eye Disease: Towards an Evidence Base for Treatment in the 21st Century
Download from www.ncbi.nlm.nih.govMissing publications? Search for publications with a matching author name.